IgE-dependent mast cell activation potentiates airway responses in murine asthma models

Susanne I. Mayr, Riaz I. Zuberi, Min Zhang, Jean De Sousa-Hitzler, Karen Ngo, Yasuko Kuwabara, Lan Yu, Wai Ping Fung-Leung, Fu-Tong Liu

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

We have studied murine models of asthma using FcεRIα-chain-deficient (FcεRIα-/-) mice to investigate the role of IgE-dependent mast cell activation in these models. When mice were either 1) immunized once with OVA in alum i.p. and then challenged with OVA intranasally, or 2) repeatedly immunized with OVA in the absence of adjuvant and subsequently challenged with nebulized OVA, FcεRα-/- mice had significantly fewer eosinophils and lower IL-4 levels in their bronchoalveolar lavage fluid compared with wild-type mice. When mice were given anti-IL-5 antibody before OVA challenge in protocol 1, eosinophilic infiltration into the airways was significantly suppressed in both genotypes, but only FcεRIα-/- mice showed significantly reduced airway hyperresponsiveness (AHR). In addition, when mice immunized and challenged with OVA also received a late OVA provocation at a higher concentration and were then exposed to methacholine, only wild-type mice developed a substantial increase in AHR. Since FcεRI is expressed mainly on mast cells in mouse airways, we conclude that IgE-dependent activation of this cell type plays an important role in the development of allergic airway inflammation and AHR in mice. The models used may be of value for testing inhibitors of IgE or mast cells for development of therapeutic agents for human asthma.

Original languageEnglish (US)
Pages (from-to)2061-2068
Number of pages8
JournalJournal of Immunology
Volume169
Issue number4
StatePublished - Aug 15 2002

Fingerprint

Mast Cells
Immunoglobulin E
Asthma
Methacholine Chloride
Interleukin-5
Bronchoalveolar Lavage Fluid
Eosinophils
Interleukin-4
Genotype
Inflammation
Antibodies

ASJC Scopus subject areas

  • Immunology

Cite this

Mayr, S. I., Zuberi, R. I., Zhang, M., De Sousa-Hitzler, J., Ngo, K., Kuwabara, Y., ... Liu, F-T. (2002). IgE-dependent mast cell activation potentiates airway responses in murine asthma models. Journal of Immunology, 169(4), 2061-2068.

IgE-dependent mast cell activation potentiates airway responses in murine asthma models. / Mayr, Susanne I.; Zuberi, Riaz I.; Zhang, Min; De Sousa-Hitzler, Jean; Ngo, Karen; Kuwabara, Yasuko; Yu, Lan; Fung-Leung, Wai Ping; Liu, Fu-Tong.

In: Journal of Immunology, Vol. 169, No. 4, 15.08.2002, p. 2061-2068.

Research output: Contribution to journalArticle

Mayr, SI, Zuberi, RI, Zhang, M, De Sousa-Hitzler, J, Ngo, K, Kuwabara, Y, Yu, L, Fung-Leung, WP & Liu, F-T 2002, 'IgE-dependent mast cell activation potentiates airway responses in murine asthma models', Journal of Immunology, vol. 169, no. 4, pp. 2061-2068.
Mayr SI, Zuberi RI, Zhang M, De Sousa-Hitzler J, Ngo K, Kuwabara Y et al. IgE-dependent mast cell activation potentiates airway responses in murine asthma models. Journal of Immunology. 2002 Aug 15;169(4):2061-2068.
Mayr, Susanne I. ; Zuberi, Riaz I. ; Zhang, Min ; De Sousa-Hitzler, Jean ; Ngo, Karen ; Kuwabara, Yasuko ; Yu, Lan ; Fung-Leung, Wai Ping ; Liu, Fu-Tong. / IgE-dependent mast cell activation potentiates airway responses in murine asthma models. In: Journal of Immunology. 2002 ; Vol. 169, No. 4. pp. 2061-2068.
@article{080f47125a224c7e905196241e93a785,
title = "IgE-dependent mast cell activation potentiates airway responses in murine asthma models",
abstract = "We have studied murine models of asthma using FcεRIα-chain-deficient (FcεRIα-/-) mice to investigate the role of IgE-dependent mast cell activation in these models. When mice were either 1) immunized once with OVA in alum i.p. and then challenged with OVA intranasally, or 2) repeatedly immunized with OVA in the absence of adjuvant and subsequently challenged with nebulized OVA, FcεRα-/- mice had significantly fewer eosinophils and lower IL-4 levels in their bronchoalveolar lavage fluid compared with wild-type mice. When mice were given anti-IL-5 antibody before OVA challenge in protocol 1, eosinophilic infiltration into the airways was significantly suppressed in both genotypes, but only FcεRIα-/- mice showed significantly reduced airway hyperresponsiveness (AHR). In addition, when mice immunized and challenged with OVA also received a late OVA provocation at a higher concentration and were then exposed to methacholine, only wild-type mice developed a substantial increase in AHR. Since FcεRI is expressed mainly on mast cells in mouse airways, we conclude that IgE-dependent activation of this cell type plays an important role in the development of allergic airway inflammation and AHR in mice. The models used may be of value for testing inhibitors of IgE or mast cells for development of therapeutic agents for human asthma.",
author = "Mayr, {Susanne I.} and Zuberi, {Riaz I.} and Min Zhang and {De Sousa-Hitzler}, Jean and Karen Ngo and Yasuko Kuwabara and Lan Yu and Fung-Leung, {Wai Ping} and Fu-Tong Liu",
year = "2002",
month = "8",
day = "15",
language = "English (US)",
volume = "169",
pages = "2061--2068",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "4",

}

TY - JOUR

T1 - IgE-dependent mast cell activation potentiates airway responses in murine asthma models

AU - Mayr, Susanne I.

AU - Zuberi, Riaz I.

AU - Zhang, Min

AU - De Sousa-Hitzler, Jean

AU - Ngo, Karen

AU - Kuwabara, Yasuko

AU - Yu, Lan

AU - Fung-Leung, Wai Ping

AU - Liu, Fu-Tong

PY - 2002/8/15

Y1 - 2002/8/15

N2 - We have studied murine models of asthma using FcεRIα-chain-deficient (FcεRIα-/-) mice to investigate the role of IgE-dependent mast cell activation in these models. When mice were either 1) immunized once with OVA in alum i.p. and then challenged with OVA intranasally, or 2) repeatedly immunized with OVA in the absence of adjuvant and subsequently challenged with nebulized OVA, FcεRα-/- mice had significantly fewer eosinophils and lower IL-4 levels in their bronchoalveolar lavage fluid compared with wild-type mice. When mice were given anti-IL-5 antibody before OVA challenge in protocol 1, eosinophilic infiltration into the airways was significantly suppressed in both genotypes, but only FcεRIα-/- mice showed significantly reduced airway hyperresponsiveness (AHR). In addition, when mice immunized and challenged with OVA also received a late OVA provocation at a higher concentration and were then exposed to methacholine, only wild-type mice developed a substantial increase in AHR. Since FcεRI is expressed mainly on mast cells in mouse airways, we conclude that IgE-dependent activation of this cell type plays an important role in the development of allergic airway inflammation and AHR in mice. The models used may be of value for testing inhibitors of IgE or mast cells for development of therapeutic agents for human asthma.

AB - We have studied murine models of asthma using FcεRIα-chain-deficient (FcεRIα-/-) mice to investigate the role of IgE-dependent mast cell activation in these models. When mice were either 1) immunized once with OVA in alum i.p. and then challenged with OVA intranasally, or 2) repeatedly immunized with OVA in the absence of adjuvant and subsequently challenged with nebulized OVA, FcεRα-/- mice had significantly fewer eosinophils and lower IL-4 levels in their bronchoalveolar lavage fluid compared with wild-type mice. When mice were given anti-IL-5 antibody before OVA challenge in protocol 1, eosinophilic infiltration into the airways was significantly suppressed in both genotypes, but only FcεRIα-/- mice showed significantly reduced airway hyperresponsiveness (AHR). In addition, when mice immunized and challenged with OVA also received a late OVA provocation at a higher concentration and were then exposed to methacholine, only wild-type mice developed a substantial increase in AHR. Since FcεRI is expressed mainly on mast cells in mouse airways, we conclude that IgE-dependent activation of this cell type plays an important role in the development of allergic airway inflammation and AHR in mice. The models used may be of value for testing inhibitors of IgE or mast cells for development of therapeutic agents for human asthma.

UR - http://www.scopus.com/inward/record.url?scp=0037103162&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037103162&partnerID=8YFLogxK

M3 - Article

VL - 169

SP - 2061

EP - 2068

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 4

ER -